For research use only. Not for therapeutic Use.
RCGD423 (Cat No.:I019699) is a compound that acts as a Glycoprotein130 (gp130) signal modulator. It has shown potential in preclinical studies for regulating cartilage growth and differentiation. In vitro research indicates RCGD423 prevents articular cartilage degeneration and promotes repair, while in vivo studies demonstrate its ability to reduce cartilage hypertrophy, loss, and degeneration, and enhance cartilage healing in injury models.
| Catalog Number | I019699 |
| CAS Number | 108237-91-8 |
| Molecular Formula | C₁₅H₁₁BrN₂S |
| Purity | ≥95% |
| Target | Interleukin Related |
| IUPAC Name | N-(4-bromophenyl)-4-phenyl-1,3-thiazol-2-amine |
| InChI | InChI=1S/C15H11BrN2S/c16-12-6-8-13(9-7-12)17-15-18-14(10-19-15)11-4-2-1-3-5-11/h1-10H,(H,17,18) |
| InChIKey | OUFYYVAASPLOAA-UHFFFAOYSA-N |
| SMILES | C1=CC=C(C=C1)C2=CSC(=N2)NC3=CC=C(C=C3)Br |
